Panvax: Phase II data

CSL Ltd. (ASX:CSL), Melbourne, Australia Product: Panvax ( Influenza A/H1N1 2009 vaccine) ( CSL425) Business: Infectious Molecular target: NA Description: Swine influenza A (H1N1) vaccine Indication:...